IBDEI2YE ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,47136,2)
;;=^5008522
;;^UTILITY(U,$J,358.3,47137,0)
;;=I69.959^^181^2355^19
;;^UTILITY(U,$J,358.3,47137,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47137,1,3,0)
;;=3^Hemiplegia/Hemiparesis Following Unspec Cerebrovascular Disease
;;^UTILITY(U,$J,358.3,47137,1,4,0)
;;=4^I69.959
;;^UTILITY(U,$J,358.3,47137,2)
;;=^5007563
;;^UTILITY(U,$J,358.3,47138,0)
;;=D89.2^^181^2355^30
;;^UTILITY(U,$J,358.3,47138,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47138,1,3,0)
;;=3^Hypergammaglobulinemia,Unspec
;;^UTILITY(U,$J,358.3,47138,1,4,0)
;;=4^D89.2
;;^UTILITY(U,$J,358.3,47138,2)
;;=^5002455
;;^UTILITY(U,$J,358.3,47139,0)
;;=B19.10^^181^2355^23
;;^UTILITY(U,$J,358.3,47139,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47139,1,3,0)
;;=3^Hepatitis B w/o Hepatic Coma
;;^UTILITY(U,$J,358.3,47139,1,4,0)
;;=4^B19.10
;;^UTILITY(U,$J,358.3,47139,2)
;;=^5000552
;;^UTILITY(U,$J,358.3,47140,0)
;;=B17.10^^181^2355^24
;;^UTILITY(U,$J,358.3,47140,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47140,1,3,0)
;;=3^Hepatitis C w/o Hepatic Coma,Acute
;;^UTILITY(U,$J,358.3,47140,1,4,0)
;;=4^B17.10
;;^UTILITY(U,$J,358.3,47140,2)
;;=^5000542
;;^UTILITY(U,$J,358.3,47141,0)
;;=B18.2^^181^2355^25
;;^UTILITY(U,$J,358.3,47141,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47141,1,3,0)
;;=3^Hepatitis C,Chr/Carrier
;;^UTILITY(U,$J,358.3,47141,1,4,0)
;;=4^B18.2
;;^UTILITY(U,$J,358.3,47141,2)
;;=^5000548
;;^UTILITY(U,$J,358.3,47142,0)
;;=E03.9^^181^2355^39
;;^UTILITY(U,$J,358.3,47142,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47142,1,3,0)
;;=3^Hypothyroidism,Unspec
;;^UTILITY(U,$J,358.3,47142,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,47142,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,47143,0)
;;=E16.2^^181^2355^36
;;^UTILITY(U,$J,358.3,47143,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47143,1,3,0)
;;=3^Hypoglycemia,Unspec
;;^UTILITY(U,$J,358.3,47143,1,4,0)
;;=4^E16.2
;;^UTILITY(U,$J,358.3,47143,2)
;;=^5002708
;;^UTILITY(U,$J,358.3,47144,0)
;;=E78.1^^181^2355^31
;;^UTILITY(U,$J,358.3,47144,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47144,1,3,0)
;;=3^Hyperglyceridemia,Pure
;;^UTILITY(U,$J,358.3,47144,1,4,0)
;;=4^E78.1
;;^UTILITY(U,$J,358.3,47144,2)
;;=^101303
;;^UTILITY(U,$J,358.3,47145,0)
;;=E78.5^^181^2355^34
;;^UTILITY(U,$J,358.3,47145,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47145,1,3,0)
;;=3^Hyperlipidemia,Unspec
;;^UTILITY(U,$J,358.3,47145,1,4,0)
;;=4^E78.5
;;^UTILITY(U,$J,358.3,47145,2)
;;=^5002969
;;^UTILITY(U,$J,358.3,47146,0)
;;=E87.1^^181^2355^35
;;^UTILITY(U,$J,358.3,47146,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47146,1,3,0)
;;=3^Hypo-osmolatlity & Hyponatremia
;;^UTILITY(U,$J,358.3,47146,1,4,0)
;;=4^E87.1
;;^UTILITY(U,$J,358.3,47146,2)
;;=^5003019
;;^UTILITY(U,$J,358.3,47147,0)
;;=E87.5^^181^2355^32
;;^UTILITY(U,$J,358.3,47147,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47147,1,3,0)
;;=3^Hyperkalemia
;;^UTILITY(U,$J,358.3,47147,1,4,0)
;;=4^E87.5
;;^UTILITY(U,$J,358.3,47147,2)
;;=^60041
;;^UTILITY(U,$J,358.3,47148,0)
;;=E87.6^^181^2355^37
;;^UTILITY(U,$J,358.3,47148,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47148,1,3,0)
;;=3^Hypokalemia
;;^UTILITY(U,$J,358.3,47148,1,4,0)
;;=4^E87.6
;;^UTILITY(U,$J,358.3,47148,2)
;;=^60610
;;^UTILITY(U,$J,358.3,47149,0)
;;=G81.90^^181^2355^18
;;^UTILITY(U,$J,358.3,47149,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2YE 3768 printed Apr 09, 2024@21:51:45 Page 2
IBDEI2YE ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,47136,2)
+2 ;;=^5008522
+3 ;;^UTILITY(U,$J,358.3,47137,0)
+4 ;;=I69.959^^181^2355^19
+5 ;;^UTILITY(U,$J,358.3,47137,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,47137,1,3,0)
+8 ;;=3^Hemiplegia/Hemiparesis Following Unspec Cerebrovascular Disease
+9 ;;^UTILITY(U,$J,358.3,47137,1,4,0)
+10 ;;=4^I69.959
+11 ;;^UTILITY(U,$J,358.3,47137,2)
+12 ;;=^5007563
+13 ;;^UTILITY(U,$J,358.3,47138,0)
+14 ;;=D89.2^^181^2355^30
+15 ;;^UTILITY(U,$J,358.3,47138,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,47138,1,3,0)
+18 ;;=3^Hypergammaglobulinemia,Unspec
+19 ;;^UTILITY(U,$J,358.3,47138,1,4,0)
+20 ;;=4^D89.2
+21 ;;^UTILITY(U,$J,358.3,47138,2)
+22 ;;=^5002455
+23 ;;^UTILITY(U,$J,358.3,47139,0)
+24 ;;=B19.10^^181^2355^23
+25 ;;^UTILITY(U,$J,358.3,47139,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,47139,1,3,0)
+28 ;;=3^Hepatitis B w/o Hepatic Coma
+29 ;;^UTILITY(U,$J,358.3,47139,1,4,0)
+30 ;;=4^B19.10
+31 ;;^UTILITY(U,$J,358.3,47139,2)
+32 ;;=^5000552
+33 ;;^UTILITY(U,$J,358.3,47140,0)
+34 ;;=B17.10^^181^2355^24
+35 ;;^UTILITY(U,$J,358.3,47140,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,47140,1,3,0)
+38 ;;=3^Hepatitis C w/o Hepatic Coma,Acute
+39 ;;^UTILITY(U,$J,358.3,47140,1,4,0)
+40 ;;=4^B17.10
+41 ;;^UTILITY(U,$J,358.3,47140,2)
+42 ;;=^5000542
+43 ;;^UTILITY(U,$J,358.3,47141,0)
+44 ;;=B18.2^^181^2355^25
+45 ;;^UTILITY(U,$J,358.3,47141,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,47141,1,3,0)
+48 ;;=3^Hepatitis C,Chr/Carrier
+49 ;;^UTILITY(U,$J,358.3,47141,1,4,0)
+50 ;;=4^B18.2
+51 ;;^UTILITY(U,$J,358.3,47141,2)
+52 ;;=^5000548
+53 ;;^UTILITY(U,$J,358.3,47142,0)
+54 ;;=E03.9^^181^2355^39
+55 ;;^UTILITY(U,$J,358.3,47142,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,47142,1,3,0)
+58 ;;=3^Hypothyroidism,Unspec
+59 ;;^UTILITY(U,$J,358.3,47142,1,4,0)
+60 ;;=4^E03.9
+61 ;;^UTILITY(U,$J,358.3,47142,2)
+62 ;;=^5002476
+63 ;;^UTILITY(U,$J,358.3,47143,0)
+64 ;;=E16.2^^181^2355^36
+65 ;;^UTILITY(U,$J,358.3,47143,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,47143,1,3,0)
+68 ;;=3^Hypoglycemia,Unspec
+69 ;;^UTILITY(U,$J,358.3,47143,1,4,0)
+70 ;;=4^E16.2
+71 ;;^UTILITY(U,$J,358.3,47143,2)
+72 ;;=^5002708
+73 ;;^UTILITY(U,$J,358.3,47144,0)
+74 ;;=E78.1^^181^2355^31
+75 ;;^UTILITY(U,$J,358.3,47144,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,47144,1,3,0)
+78 ;;=3^Hyperglyceridemia,Pure
+79 ;;^UTILITY(U,$J,358.3,47144,1,4,0)
+80 ;;=4^E78.1
+81 ;;^UTILITY(U,$J,358.3,47144,2)
+82 ;;=^101303
+83 ;;^UTILITY(U,$J,358.3,47145,0)
+84 ;;=E78.5^^181^2355^34
+85 ;;^UTILITY(U,$J,358.3,47145,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,47145,1,3,0)
+88 ;;=3^Hyperlipidemia,Unspec
+89 ;;^UTILITY(U,$J,358.3,47145,1,4,0)
+90 ;;=4^E78.5
+91 ;;^UTILITY(U,$J,358.3,47145,2)
+92 ;;=^5002969
+93 ;;^UTILITY(U,$J,358.3,47146,0)
+94 ;;=E87.1^^181^2355^35
+95 ;;^UTILITY(U,$J,358.3,47146,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,47146,1,3,0)
+98 ;;=3^Hypo-osmolatlity & Hyponatremia
+99 ;;^UTILITY(U,$J,358.3,47146,1,4,0)
+100 ;;=4^E87.1
+101 ;;^UTILITY(U,$J,358.3,47146,2)
+102 ;;=^5003019
+103 ;;^UTILITY(U,$J,358.3,47147,0)
+104 ;;=E87.5^^181^2355^32
+105 ;;^UTILITY(U,$J,358.3,47147,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,47147,1,3,0)
+108 ;;=3^Hyperkalemia
+109 ;;^UTILITY(U,$J,358.3,47147,1,4,0)
+110 ;;=4^E87.5
+111 ;;^UTILITY(U,$J,358.3,47147,2)
+112 ;;=^60041
+113 ;;^UTILITY(U,$J,358.3,47148,0)
+114 ;;=E87.6^^181^2355^37
+115 ;;^UTILITY(U,$J,358.3,47148,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,47148,1,3,0)
+118 ;;=3^Hypokalemia
+119 ;;^UTILITY(U,$J,358.3,47148,1,4,0)
+120 ;;=4^E87.6
+121 ;;^UTILITY(U,$J,358.3,47148,2)
+122 ;;=^60610
+123 ;;^UTILITY(U,$J,358.3,47149,0)
+124 ;;=G81.90^^181^2355^18
+125 ;;^UTILITY(U,$J,358.3,47149,1,0)
+126 ;;=^358.31IA^4^2
